Yanou Engelen

Journal Article
A1
open access

Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy

Yanou Engelen (UGent) , Robin Demuynck (UGent) , Jana Ramon (UGent) , K. Breckpot, Stefaan De Smedt (UGent) , Guillaume Lajoinie, Kevin Braeckmans (UGent) , Dmitri Krysko (UGent) and Ine Lentacker (UGent)

(2025) JOURNAL OF CONTROLLED RELEASE. 384.

Add to list

Journal Article
A1
open access

Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs

Sofie Meulewaeter (UGent) , Margo De Velder (UGent) , Diethard Reckelbus (UGent) , Kevin Mwangi (UGent) , Thomas Ehouarne (UGent) , Ilke Aernout (UGent) , Yanou Engelen (UGent) , Fëllanza Halimi (UGent) , Isis Van herteryck (UGent) , Lobke De Bels (UGent) , et al.

(2025) MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT. 33(2).

Add to list

Journal Article
A1
open access

Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool

Yanou Engelen (UGent) , Dmitri Krysko (UGent) , Iuliia Efimova (UGent) , Karine Breckpot, Michel Versluis, Stefaan De Smedt (UGent) , Guillaume Lajoinie and Ine Lentacker (UGent)

(2024) JOURNAL OF CONTROLLED RELEASE. 375. p.389-403

Add to list

Journal Article
A1
open access

Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy

Robin Demuynck (UGent) , Yanou Engelen (UGent) , Andre Skirtach (UGent) , Stefaan De Smedt (UGent) , Ine Lentacker (UGent) and Dmitri Krysko (UGent)

(2024) TRENDS IN CANCER. 10(6). p.486-489

Add to list

Journal Article
A1
open access

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Sofie Meulewaeter (UGent) , Ilke Aernout (UGent) , Joke Deprez (UGent) , Yanou Engelen (UGent) , Margo De Velder (UGent) , Lorenzo Franceschini, Karine Breckpot, Serge Van Calenbergh (UGent) , Caroline Asselman (UGent) , Katie Boucher (UGent) , et al.

(2024) JOURNAL OF CONTROLLED RELEASE. 370. p.379-391

Add to list

Journal Article
A1
open access

Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics

Jana Ramon (UGent) , Yanou Engelen (UGent) , Herlinde De Keersmaecker (UGent) , Ilia Goemaere (UGent) , Deep Punj (UGent) , Julián Mejía Morales (UGent) , Cédric Bonte, Geert Berx (UGent) , Esther Hoste (UGent) , Stephan Stremersch, et al.

(2024) JOURNAL OF CONTROLLED RELEASE. 365. p.1019-1036

Add to list

Journal Article
A1
open access

Opening doors with ultrasound and microbubbles : beating biological barriers to promote drug delivery

Joke Deprez (UGent) , G. Lajoinie, Yanou Engelen (UGent) , Stefaan De Smedt (UGent) and Ine Lentacker (UGent)

(2021) ADVANCED DRUG DELIVERY REVIEWS. 172. p.9-36

Academic Bibliography

Yanou Engelen

Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy

Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs

Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool

Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics

Opening doors with ultrasound and microbubbles : beating biological barriers to promote drug delivery

Contents

Support

Contact